First Eagle Investment Management LLC Purchases 186,668 Shares of InfuSystem Holdings, Inc. (NYSE:INFU)

First Eagle Investment Management LLC boosted its position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 25.9% during the 4th quarter, HoldingsChannel reports. The fund owned 908,371 shares of the company’s stock after buying an additional 186,668 shares during the quarter. First Eagle Investment Management LLC’s holdings in InfuSystem were worth $7,676,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its stake in InfuSystem by 14.3% during the fourth quarter. Bank of New York Mellon Corp now owns 91,219 shares of the company’s stock valued at $771,000 after acquiring an additional 11,436 shares during the period. Legato Capital Management LLC bought a new position in InfuSystem during the fourth quarter valued at about $85,000. JPMorgan Chase & Co. increased its stake in InfuSystem by 74.1% during the third quarter. JPMorgan Chase & Co. now owns 15,556 shares of the company’s stock valued at $104,000 after acquiring an additional 6,623 shares during the period. Barclays PLC increased its stake in InfuSystem by 300.5% during the third quarter. Barclays PLC now owns 28,597 shares of the company’s stock valued at $192,000 after acquiring an additional 21,457 shares during the period. Finally, Geode Capital Management LLC increased its stake in InfuSystem by 1.8% during the third quarter. Geode Capital Management LLC now owns 436,508 shares of the company’s stock valued at $2,925,000 after acquiring an additional 7,550 shares during the period. 71.13% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday.

InfuSystem Trading Up 1.6 %

INFU stock opened at $5.55 on Friday. InfuSystem Holdings, Inc. has a 1-year low of $5.28 and a 1-year high of $9.97. The firm has a market cap of $116.60 million, a P/E ratio of 92.52 and a beta of 1.75. The business’s 50 day moving average is $7.65 and its 200-day moving average is $7.55. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.